Klaus Geissler

Title: Klaus Geissler: Innovator in Nucleic Acid Adsorption

Introduction

Klaus Geissler, an accomplished inventor based in Oberhausen, Germany, has made significant contributions to the field of molecular biology through his innovative work on nucleic acids. With a focus on adsorption methods, Geissler's patent presents a novel approach that aids in the efficient isolation of nucleic acids from biological samples.

Latest Patents

Klaus Geissler holds a patent titled "Adsorption of nucleic acids to a solid phase." This invention describes a method for non-covalently binding nucleic acids to a solid phase through a systematic two-step procedure. The first step involves the lysis of a biological sample by mixing it with an aqueous lysis buffer that contains a chaotropic agent, followed by an incubation period. The second step increases the concentration of the chaotropic agent and contacts the mixture with the solid phase, which effectively adsorbs the nucleic acids from the liquid phase.

Career Highlights

Geissler is associated with Roche Diagnostics Operations, Inc., a leading company known for its innovative contributions to the diagnostics industry. His work there showcases his dedication to advancing scientific research and improving methodologies in nucleic acid isolation.

Collaborations

Throughout his career, Klaus has worked alongside notable colleagues including Ralf Zielenski and Thomas Walter. Their collaborative efforts have undoubtedly enriched the research environment at Roche and fostered a spirit of innovation that drives their projects forward.

Conclusion

Klaus Geissler exemplifies the spirit of innovation in the scientific field, particularly in the area of molecular biology. His pioneering patent on nucleic acid adsorption demonstrates his commitment to enhancing research techniques, benefitting both academia and industry. As he continues his work at Roche Diagnostics, his contributions will likely influence future advancements in molecular diagnostics and beyond.